fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

AbbVie announces extension of review for supplemental NDA of upadacitinib to treat psoriatic arthritis

Written by | 26 Mar 2021

AbbVie announced that the FDA has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic… read more.

Lung cancer resistance: the key is glucose

Written by | 26 Mar 2021

Cancers are not only made of tumour cells. In fact, as they grow, they develop an entire cellular ecosystem within and around them. This “tumour microenvironment” is made… read more.

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

Interview and article by Christine Clark. The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.